Corpus Intelligence IC Memo — AVERA WESKOTA MEMORIAL MEDICAL CENTE 2026-04-26 15:12 UTC
IC Memo — AVERA WESKOTA MEMORIAL MEDICAL CENTE
Investment Committee Memorandum | SD | 16 beds | Grade D | EBITDA uplift $412K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

AVERA WESKOTA MEMORIAL MEDICAL CENTE

CCN 431324 | JERAULD, SD | 16 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

AVERA WESKOTA MEMORIAL MEDICAL CENTE is a 16-bed rural/critical access in JERAULD, SD with $5.4M in net patient revenue and a 13.0% operating margin. The hospital serves a payer mix of 89.2% Medicare, 4.8% Medicaid, and 6.0% commercial.

Thesis: Turnaround. Our ML models identify $412K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 13.0% to 20.6% (+757bps).

Net Revenue HCRIS$5.4M
Current EBITDA COMPUTED$708K
Operating Margin COMPUTED13.0%
Occupancy HCRIS9.6%
Revenue / Bed COMPUTED$340K
Net-to-Gross HCRIS62.3%
Distress Probability ML64.5%

2. Market Context & Competitive Position

63
SD Hospitals
-3.2%
State Median Margin
38
Comparable Hospitals

SD has 63 Medicare-certified hospitals with a median operating margin of -3.2%. The target's margin of 13.0% places it above the state median. Among 38 size-comparable peers (8-32 beds), the median margin is -2.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (8-32), prioritizing same-state peers. 38 hospitals in the comp set.

HospitalStateBedsRevenueMargin
AVERA WESKOTA MEMORIAL MEDICAL (Target)SD16$5.4M13.0%
AVERA QUEEN OF PEACESD25$122.9M-5.8%
MONUMENT HEALTH SPEARFISH HOSPSD27$116.6M1.9%
BLACK HILLS SURGICAL HOSPITAL SD26$91.1M15.3%
HURON REGIONAL MEDICAL CENTERSD25$49.4M-5.9%
MONUMENT HEALTH STURGIS REGIONSD25$39.1M-3.3%
MADISON REGIONAL HEALTH SYSTEMSD22$33.8M-1.6%
SANFORD MEDICAL CENTER VERMILLSD25$32.0M8.3%
FALL RIVER HOSPITALSD25$28.4M0.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $412K (757bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$114K+210bp18mo
Denial Rate Reduction12.0%6.5%$113K+208bp12mo
Cost to Collect4.5%2.5%$109K+200bp12mo
A/R Days Reduction5200.0%3800.0%$66K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+18bp6mo

5. EBITDA Bridge

Net Collection Rate
$114K
Denial Rate Reduction
$113K
Cost to Collect
$109K
A/R Days Reduction
$66K
Clean Claim Rate
$10K
Total EBITDA Uplift$412K
Current EBITDA$708K
+ RCM Uplift+$412K
Pro Forma EBITDA$1.1M
Current Margin13.0%
Pro Forma Margin20.6%
WC Released (1x)$209K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$1.1M$8.8M8.07x51.8%
Base (11x exit)10.0x11.0x$1.1M$10.0M9.20x55.9%
Bull Case9.0x11.0x$980K$11.7M11.98x64.3%
Bull (12x exit)9.0x12.0x$980K$13.1M13.36x67.9%
Bear Case11.0x10.0x$1.2M$6.4M5.32x39.7%
Bear (11x exit)11.0x11.0x$1.2M$7.4M6.18x44.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 89.2% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement
MediumLow occupancyAt 9.6%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 64.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 38 hospitals with 8-32 beds
  • Same-state prioritization (n=41)
  • Comp margins: P25=-9.6% / P50=-2.4% / P75=6.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.